Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 1
1993 1
1994 2
1995 2
1996 1
1997 5
1998 4
1999 2
2000 3
2001 7
2002 3
2003 5
2004 4
2005 7
2006 15
2007 4
2008 10
2009 9
2010 11
2011 9
2012 9
2013 6
2014 10
2015 13
2016 12
2017 15
2018 20
2019 13
2020 12
2021 12
2022 11
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
The neuropsychiatry of Parkinson's disease: advances and challenges.
Weintraub D, Aarsland D, Chaudhuri KR, Dobkin RD, Leentjens AF, Rodriguez-Violante M, Schrag A. Weintraub D, et al. Lancet Neurol. 2022 Jan;21(1):89-102. doi: 10.1016/S1474-4422(21)00330-6. Lancet Neurol. 2022. PMID: 34942142 Free PMC article. Review.
In people with Parkinson's disease, neuropsychiatric signs and symptoms are common throughout the disease course. ...The underlying neurobiology of these presentations is complex and not well understood, with the strongest evidence for neuropathological chang …
In people with Parkinson's disease, neuropsychiatric signs and symptoms are common throughout the disease course. ...Th …
Epilepsy in neurodegenerative diseases.
Neri S, Mastroianni G, Gardella E, Aguglia U, Rubboli G. Neri S, et al. Epileptic Disord. 2022 Apr 1;24(2):249-273. doi: 10.1684/epd.2021.1406. Epileptic Disord. 2022. PMID: 35596580 Review.
In this seminar, we provide an updated overview of the clinical features, pathophysiological mechanisms and diagnostic and treatment approaches of epilepsy in the most common neurodegenerative disorders (such as Alzheimer disease and other types of dementia, Parkinson
In this seminar, we provide an updated overview of the clinical features, pathophysiological mechanisms and diagnostic and treatment approac …
Wilson's disease and other neurological copper disorders.
Bandmann O, Weiss KH, Kaler SG. Bandmann O, et al. Lancet Neurol. 2015 Jan;14(1):103-13. doi: 10.1016/S1474-4422(14)70190-5. Lancet Neurol. 2015. PMID: 25496901 Free PMC article. Review.
Early-onset presentations in infancy and late-onset manifestations in adults older than 70 years of age are now well recognised. ...Disordered copper metabolism is also associated with other neurological conditions, including a subtype of axonal neuropathy due to AT …
Early-onset presentations in infancy and late-onset manifestations in adults older than 70 years of age are now well recognise …
A Practical Approach to Early-Onset Parkinsonism.
Riboldi GM, Frattini E, Monfrini E, Frucht SJ, Di Fonzo A. Riboldi GM, et al. J Parkinsons Dis. 2022;12(1):1-26. doi: 10.3233/JPD-212815. J Parkinsons Dis. 2022. PMID: 34569973 Free PMC article. Review.
Early-onset parkinsonism (EO parkinsonism), defined as subjects with disease onset before the age of 40 or 50 years, can be the main clinical presentation of a variety of conditions that are important to differentiate. Although rarer than classical late-onset
Early-onset parkinsonism (EO parkinsonism), defined as subjects with disease onset before the age of 40 or 50 years, can be the main …
Young Onset Parkinson's Disease: A Modern and Tailored Approach.
Post B, van den Heuvel L, van Prooije T, van Ruissen X, van de Warrenburg B, Nonnekes J. Post B, et al. J Parkinsons Dis. 2020;10(s1):S29-S36. doi: 10.3233/JPD-202135. J Parkinsons Dis. 2020. PMID: 32651336 Free PMC article. Review.
In people with young onset Parkinson's disease (YOPD), onset of symptoms is between 21 and 40 years of age. The distinction between YOPD and late-onset Parkinson's disease is supported by genetic differences (a genetic etiology is more co …
In people with young onset Parkinson's disease (YOPD), onset of symptoms is between 21 and 40 years of age. The distinction be …
Young-onset Parkinson's disease: Its unique features and their impact on quality of life.
Mehanna R, Jankovic J. Mehanna R, et al. Parkinsonism Relat Disord. 2019 Aug;65:39-48. doi: 10.1016/j.parkreldis.2019.06.001. Epub 2019 Jun 1. Parkinsonism Relat Disord. 2019. PMID: 31176633 Review.
Young-onset Parkinson's disease (YOPD), defined as age at onset between 21 and 40 years, presents unique motor and non-motor features that differentiate this subtype from the typical late onset Parkinson's disease (LOPD), starting after a …
Young-onset Parkinson's disease (YOPD), defined as age at onset between 21 and 40 years, presents unique motor and non-motor f …
Neuroimaging in aging and neurologic diseases.
Risacher SL, Saykin AJ. Risacher SL, et al. Handb Clin Neurol. 2019;167:191-227. doi: 10.1016/B978-0-12-804766-8.00012-1. Handb Clin Neurol. 2019. PMID: 31753134 Free PMC article. Review.
The spectrum covers neuroimaging measures from normal aging to a variety of dementias: late-onset Alzheimer's disease [AD; including mild cognitive impairment (MCI)], familial and nonfamilial early-onset AD, atypical AD syndromes, posterior cortical atrophy ( …
The spectrum covers neuroimaging measures from normal aging to a variety of dementias: late-onset Alzheimer's disease [ …
Overview of late-onset psychoses.
Devanand DP, Jeste DV, Stroup TS, Goldberg TE. Devanand DP, et al. Int Psychogeriatr. 2024 Jan;36(1):28-42. doi: 10.1017/S1041610223000157. Epub 2023 Mar 3. Int Psychogeriatr. 2024. PMID: 36866576 Review.
This overview covers the epidemiology, clinical features, neurobiology, and therapeutics of late-onset psychoses. RESULTS: Late-onset schizophrenia, delusional disorder, and psychotic depression have unique clinical characteristics. ...Research is warr …
This overview covers the epidemiology, clinical features, neurobiology, and therapeutics of late-onset psychoses. RESULTS: …
New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Puschmann A. Puschmann A. Curr Neurol Neurosci Rep. 2017 Sep;17(9):66. doi: 10.1007/s11910-017-0780-8. Curr Neurol Neurosci Rep. 2017. PMID: 28733970 Free PMC article. Review.
RECENT FINDINGS: Newly reported genes for dominant Parkinson's disease are DNAJC13, CHCHD2, and TMEM230. However, the evidence for a disease-causing role is not conclusive, and further genetic and functional studies are warranted. ...Mutations in the new domi …
RECENT FINDINGS: Newly reported genes for dominant Parkinson's disease are DNAJC13, CHCHD2, and TMEM230. However, the evidence …
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.
Fernández-Calle R, Konings SC, Frontiñán-Rubio J, García-Revilla J, Camprubí-Ferrer L, Svensson M, Martinson I, Boza-Serrano A, Venero JL, Nielsen HM, Gouras GK, Deierborg T. Fernández-Calle R, et al. Mol Neurodegener. 2022 Sep 24;17(1):62. doi: 10.1186/s13024-022-00566-4. Mol Neurodegener. 2022. PMID: 36153580 Free PMC article. Review.
There are three major human polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of the most influential risk factors for the development of late-onset Alzheimer's disease (AD). Neuroinflammation has become the third hallmark of …
There are three major human polymorphisms, apoE2, apoE3, and apoE4, and the genetic expression of APOE4 is one of the most influential risk …
223 results